Dr. John Cush RheumNow
3 years 10 months ago
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients:
- Hongbo Chi, PhD, Exploring Metabolism of Follicular Helper T Cells & Lupus Progression
- Joseph Craft, MD: Processes Enabling T Cells to Be Destructive in Lupus Nephritis
https://t.co/yI2NlCHaBi https://t.co/fevBTkaxCY
Dr. John Cush RheumNow
3 years 10 months ago
#OA phenotypes by SF cell status
- Activated: hi T-cell, low mono–macrop-PMN activated; 70% improved
- Lymphoid: hi PMN, low lymph & mono, low activ, lower pain
- Myeloid: hi NK & mono, low T-cell & activat
- Aggressive: hi lymph/macr/NK/PMN;39%improve
-https://t.co/3DXPoDE5Pm https://t.co/VRJkscAm5a
The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. This review examines the available clinical literature on the potential benefits and outcomes of JAK inhibitor use in SSc=ILD.
The American College of Rheumatology (ACR) released a summary of its new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis. This is the first ACR guideline about an integrative approach to Rheumatoid Arthritis (RA) and it is considered complementary to the ACR’s 2021 Guideline for the Treatment of RA, which covers pharmacologic therapies.
Dr. John Cush RheumNow
3 years 10 months ago
Comorbidities in Axial Spondyloarthritis
Dr. Antoni Chan discusses Abstract 1609 at ACR22 Convergence.
https://t.co/dCLlgiGV9K https://t.co/a4iI1q3zZC
Dr. John Cush RheumNow
3 years 10 months ago
Will a vegetarian diet and exercise actually help RA disease activity?
https://t.co/NI6xmhN0sO https://t.co/7IlQWkXkE1
Dr. John Cush RheumNow
3 years 10 months ago
A&R: Climate Emergency and the Health of Our Patients
- A public health crisis that will affect Rheum pts
- climate factors can worsen Dz
- Pollution causes autoimmunity
- Climates worse effects on the vulnerable
- Advocacy solutions research are needed https://t.co/JJufiImhND
Dr. John Cush RheumNow
3 years 10 months ago
Efgartigimod Treatment in Chronic Primary ITP
https://t.co/iJMeG2CJJv https://t.co/OXE7CuScBC
A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus.
The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work? A new study of a weight loss and exercise program in community settings shows only marginal benefits.
Dr. John Cush RheumNow
3 years 10 months ago
Substandard Therapy in RA
Clinicians could improve outcomes in their patients w/ RA by paying attention to certain markers of care quality, like early referral to certified rheumatologists and prescribing standard drugs for RA, new research suggested.
https://t.co/Ln6XQHLVJE https://t.co/454Ff8dEr8
Dr. John Cush RheumNow
3 years 10 months ago
Practical Guidance for the Clinical Rheumatologist in Unplanned Pregnancies
Women of reproductive age comprise an overwhelming majority of patients with rheumatic and musculoskeletal disease.
https://t.co/45ABQ0e2Qy https://t.co/dhLqzjf9uL
Dr. John Cush RheumNow
3 years 10 months ago
NIH has granted $4.7 million to fund OHSU/UAB/UNC scientists to develop Novel 2-Pyrimidone (SRI-42718) Chikungunya antiviral drug. 2022: >360,000 Chikungunya cases w/ 77 deaths (mostly Brazil, India Guatemala) w/ 13 acquired in U.S. https://t.co/5ospHoFBBQ https://t.co/E1WKvdhaUO
Dr. John Cush RheumNow
3 years 10 months ago
Swedish study of 4033 incident RA vs 6485 controls - Exposure to occupational inhalable increased risk ACPA+ RA (OR 1.25). Occupational inhalable agents plus smoking and shared epitope markedly elevated risk (OR 18.22) esp in ACPA+RA https://t.co/4lKLEhkURm https://t.co/HFhz8lMR10
